Nutraplus India Ltd. Stock Research

Share this page On

Nutraplus India Ltd. Detail

Nutraplus India Limited is in portfolio of Subramanian P. He is one of the top investors in India. The company belongs to Pharma sector .

The Company website is not in working condition as of this writing. I treid browsing it couple of times today as well as yesterday but it did not work. This made a bad impression in my mind about the Company.

As per Reuters website it is a veteran producer of bulk drugs/active pharmaceutical ingredients (APIs), specialty chemicals and intermediates for treatment across therapeutic areas.

The Company’s products include Nimesulide, Bromhexine HCL, Aceclofenac, Lumefantrine, Diclofenac Sodium, Albendazole, Artemether, Lumefantrine, Arteether Ornidazole, Mefenamic acid and Doxofylline.

The Company produces other complex products, such as Meta Chloro Anisloe and Meta Bromo Anisole. The Company operates through its manufacturing facilities located at Tarapur, Boisar, Maharashtra.

Now lets look at performance of this company over the years.As per Dow theory of technical analysis price performance over a period of time reflects Company state.

READ  Zodiac JRD MKJ Ltd Stock Research

Nutraplus India Ltd. Stock Performance

Nutraplus India Stock Performance
Nutraplus India Stock Performance

This stock is perfect example of stocks which go blazing based on news or operator driven. In two year period between 2015 and 2016 it rose above 200 and came down as well. It started the journey from 15 odd levels, gave more than 10 times return in short span of time and then came back to 20 odd levels.

It came down as fast as it went up. So investors investing at higher price point did not get a chance to make profit. As they will wait for turn around after stock price started tumbling. I personally dislike these types of stocks as they are not driver by fundamental but rumors.

Nutraplus India Ltd. My Opinion

Nutraplus India is in Pharma sector. But it is different from regular pharma company. It creates Capsules for Pharma Industry.

Pharma is considered as defensive sector over the years. The ace investor Subramanian P also has many Pharma companies in his portfolio. But looking at price performance and details about Nutraplus India I am not too convinced about this Company.

READ  Dhoot Industrial Finance Ltd. Stock Research

I already have one Pharma stock in my portfolio. I would advice you to ignore this Company. The price performance may attract you but it is dangerous Company in my opinion.In case you are interested then you can track the company by adding it to your stock watch list. That way you can keep close eye on the Company.


Share this page On

Leave a Reply

  Subscribe  
Notify of